People · Operator
Named in public records as an officer, director or promoter · active 2024–2026 · Pharma, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cognito Therapeutics Group, Inc. | — | Pharma | Series D+ | $196.3M | $1.7B | 2025 |
| Mirum Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $138.5M | $347.9M | 2026 |
| Cognito Therapeutics Ltd. | — | Pharma | Series D+ | $119.0M | $111.6M | 2024 |
Laura Brege at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Laura Brege on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerald Chan | 2 | 13 |
| Stephen Bruso | 2 | 9 |
| Helen Liang | 2 | 4 |
| Richard Kuntz | 2 | 4 |
| Ed Mathers | 1 | 11 |
| Patrick Heron | 1 | 11 |
| Jonathan Leff | 1 | 11 |
| Michael Grey | 1 | 10 |
| Tiba Aynechi | 1 | 9 |
| Patrick J. Heron | 1 | 7 |
| Susan Dube | 1 | 3 |
| Edward T. Mathers | 1 | 3 |
| William C. Fairey | 1 | 2 |
| Peter Radovich | 1 | 2 |
| Michael G. Grey | 1 | 2 |
| Jarod Rutledge | 1 | 2 |
| Laura J. Brege | 1 | 1 |
| Christopher J. Peetz | 1 | 1 |
| Tiba J. Aynechi | 1 | 1 |
| Chris Peetz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.